Services
Analytics
At MiraOmics, we turn complex biology and complicated analytics decisions into clear, actionable paths forward—whether you’re discovering a new target, validating a lead, or scaling your analytics organization.
Target discovery and validation through multiomics:
Uncover the right target—and prove it.
We combine single-cell, spatial, proteomics, and bulk datasets into integrated pipelines that:
Estimate and segment target populations
Identify causal genes, pathways, and mechanisms
Pinpoint the causal cell types driving disease
Match targets to the modality most likely to succeed (biologics, small molecules, cell therapy, and more)
Deliver IND-ready data packages, backed by robust, reproducible analysis
All powered by the same domain-specific infrastructure behind our biomarker, QC, and spatial integration pipelines ready to be used in clinical programs and FDA submissions.
Pipeline development:
Clinical & Translational Biomarker Pipelines
Integrated single-cell, spatial, bulk, and proteomic pipelines that surface predictive biomarkers, PD signatures, and TME stratification—including CAR-T biomarker frameworks used in FDA submissions.
Manufacturing Analytics Pipelines for Cell Therapy
Automated, reproducible pipelines for:
-
Cell-composition analysis
-
In-process control analytics
-
Release-criteria development
-
Multimodal QC data integration
Supporting clinical manufacturing consistency and regulatory requirements.
Spatial Transcriptomics + H&E Integration
Pipelines combining spatial data, histology, imaging features, and downstream single-cell integration—enabling biodistribution analysis, tissue-engineering validation, immune infiltration profiling, and mechanism-of-action discovery.
Single-Cell & Multimodal Integration Pipelines
We unify scRNA-seq, ATAC-seq, TCR/BCR, proteomics, and spatial datasets across donors and timepoints to model cell states, clonotypes, and therapeutic responses.
NGS, Legacy Data, and Platform Integration
We modernize or rebuild existing pipelines and integrate them with legacy datasets, ensuring reproducibility, scalability, and downstream compatibility.
MiraTyper: Harmonized Cell-Type Classification
Our own batch-resistant, pan-organ classification platform, MiraTyper, standardizes cell-type definitions across studies—eliminating the “every dataset, new labels” problem.
Scientific Advisory
Lean on our experience in building and leading analytics teams, from startups to big pharma. We can advise on strategy, partnership opportunity evaluation, and technology and process.
Business analytics strategy:
- CRO vs in-house?
- How many FTEs, what specialization?
- Who to hire?
- Cloud or on-premises?
- Buy vs build?
- Pharma perspective
- User experience
Bioinformatics due diligence
Are you an investor and thinking about investing in a promising biotech with a complicated drug discovery analytics platform?
- Do you need to review a NGS or multi-omics based drug identification pipeline?
- Are you thinking of investing in a data analytics provider and need a second opinion on the technology?
- Do you need to evaluate a promising candidate for a computational biology position, but do not have in-house expertise?
Other
Consulting types
Free 30 min consult
We will provide a 30 min free, complimentary consult that would help determine if our skill sets meet your goals. The call will be completely confidential, but NDA free. This call would be limited to general advice and will not provide any specific solutions.
Video/Phone consult (short term)
We can consult on specific questions regarding your project. Potential discounts are available for small clients and startups. We understand how hard it is to get started. Per/hr basis.
Analytics contract
We can handle all the data from design of experiments, to data transfer, and report generation. We have state of the art pharma grade security and best practices for handling data in a completely confidential manner. Pricing dependent on scope.